Karuna Therapeutics, Inc. Common Stock (KRTX)

KRTX was delisted on the 15th of March, 2024.

• Market cap: $12.6B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.

Employees: 210